Contract 75A50323F80022
Heyltex Corporation · Department Of Health And Human Services · September 28, 2024
Heyltex Corporation was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 28, 2024 for $4.14 million (current value) of work in pharmaceutical preparation manufacturing. Performance is in Atlanta, GA. This is a task or delivery order issued under parent IDIQ V797D70258. It uses firm fixed-price contract pricing. If all options are exercised, the contract could reach $4.14 million.
Contract details
- PIID
- 75A50323F80022
- Parent IDIQ
- V797D70258
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Atlanta, GA
- First action
- September 28, 2024
Description
THE PURPOSE OF THIS MODIFICATION IS TO PROVIDE A NO COST EXTENSION TO EXTEND THE PERIOD OF PERFORMANCE.
Modification timeline
-
September 28, 2024Mod P00003 · Change Order$4.14M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Phlow Corp. | Department Of Health And Human Services | July 2, 2026 | $696.67M |
| Sri International | Department Of Health And Human Services | July 2, 2026 | $0 |
| Pfizer Inc | Department Of Health And Human Services | June 29, 2026 | $1.12B |
| Kymanox Corp | Department Of Health And Human Services | June 25, 2026 | $0 |
| Mckesson Specialty Distribution Llc | Department Of Health And Human Services | June 24, 2026 | $203.93M |
| Mriglobal | Department Of Health And Human Services | June 24, 2026 | $514.9K |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50323F80022?
Contract 75A50323F80022 is a federal contract awarded to Heyltex Corporation by Department Of Health And Human Services on September 28, 2024 for $4.14 million of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 0 times since the base award.
Who won contract 75A50323F80022?
Heyltex Corporation won contract 75A50323F80022 from Department Of Health And Human Services.
How much is contract 75A50323F80022 worth?
Contract 75A50323F80022 has obligated $0 to date but carries a potential ceiling of $4.14 million if fully funded and all options are exercised.